Immune-associated cells in basal cell carcinomas of skin

Increased numbers of mast cells (MCs) and lymphocytes infiltrating in basal cell carcinomas (BCCs) have been observed. The presence of these infiltrating cells has been considered a sign of an immunologic anti‐tumor response in the host, but the relationship of these two cell populations has not bee...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cutaneous pathology 1996-04, Vol.23 (2), p.140-146
Hauptverfasser: Deng, J.S., Brod, B.A., Saito, R., Tharp, M.D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 146
container_issue 2
container_start_page 140
container_title Journal of cutaneous pathology
container_volume 23
creator Deng, J.S.
Brod, B.A.
Saito, R.
Tharp, M.D.
description Increased numbers of mast cells (MCs) and lymphocytes infiltrating in basal cell carcinomas (BCCs) have been observed. The presence of these infiltrating cells has been considered a sign of an immunologic anti‐tumor response in the host, but the relationship of these two cell populations has not been examined. To elucidate this possible relationship, 30 non‐ulcerated BCCs were analyzed. Frozen sections of the tumors were stained with monoclonal antibodies for Langerhans' cells, lymphocyte subsets and natural killer cells. Fluorescein isothiocynate (FITC) ‐aviclin as well as anti‐tryptase and anti‐CD45RO monoclonal antibodies were used on formalin‐fixed, paraffin‐embedded secdons for mast cell and T cell identification, respectively. B cells and natural killer cells were rarely observed in these tumors. MCs and T cells were quantified by direct enumeration and expressed as number of cells per high power field (hpf). FITC‐avidin and anti‐tryptase antibodies were equivalent in their ability to identify MCs. MC content in BCCs ranged from 1.0 to 31 cells/hpf. The number of T cells ranged from 0 to 50 cells/hpf with helper/suppressor cell ratios of 0.2 to 10. There was no correlation between helper/suppressor ratios and mast cell numbers; however, an inverse relationship was observed between the numbers of T cells and the number of mast cells in these tumors. These studies indicate that T cells and MCs are the primary immune cell populations responding to BCCs, and that decreased numbers of T cells are associated with more aggressive tumors.
doi_str_mv 10.1111/j.1600-0560.1996.tb01287.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78141751</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78141751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4360-aa26b14fd9b0f7dcac90157d5794302ad8a3a782191efd3dd1271864ac2649af3</originalsourceid><addsrcrecordid>eNqVkFtr3DAQhUVpSTdJf0LBhJI3bzWWrEseAsmSpoHQhtDQRzGWZNDGl8SzSzf_vnbX7HvnRYzOmTPDx9gZ8CWM9XW9BMV5zks1flirlpuKQ2H0cveOLQ7Se7bggotcWaM_smOiNeegjCqP2JHRBUhpFszcte22izkS9T7hJobMx6ahLHVZhYTNvzbzOPjU9S1S1tcZPafulH2osaH4aX5P2NO3m1-r7_n9z9u71dV97qVQPEcsVAWyDrbitQ4eveVQ6lBqKwUvMBgUqE0BFmIdRAhQaDBKoi-UtFiLE3a-z30Z-tdtpI1rE003YRf7LTltQIIuYTRe7I1-6ImGWLuXIbU4vDngbsLm1m5i4yY2bsLmZmxuNw5_nrdsqzaGw-jMadS_zDqSx6YesPOJDrYRsyqAj7bLve1PauLbfxzgVk8PIKeAfB-QaBN3hwAcnp3SQpfu949bJ8WjfLT82hnxFzyol00</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78141751</pqid></control><display><type>article</type><title>Immune-associated cells in basal cell carcinomas of skin</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Deng, J.S. ; Brod, B.A. ; Saito, R. ; Tharp, M.D.</creator><creatorcontrib>Deng, J.S. ; Brod, B.A. ; Saito, R. ; Tharp, M.D.</creatorcontrib><description>Increased numbers of mast cells (MCs) and lymphocytes infiltrating in basal cell carcinomas (BCCs) have been observed. The presence of these infiltrating cells has been considered a sign of an immunologic anti‐tumor response in the host, but the relationship of these two cell populations has not been examined. To elucidate this possible relationship, 30 non‐ulcerated BCCs were analyzed. Frozen sections of the tumors were stained with monoclonal antibodies for Langerhans' cells, lymphocyte subsets and natural killer cells. Fluorescein isothiocynate (FITC) ‐aviclin as well as anti‐tryptase and anti‐CD45RO monoclonal antibodies were used on formalin‐fixed, paraffin‐embedded secdons for mast cell and T cell identification, respectively. B cells and natural killer cells were rarely observed in these tumors. MCs and T cells were quantified by direct enumeration and expressed as number of cells per high power field (hpf). FITC‐avidin and anti‐tryptase antibodies were equivalent in their ability to identify MCs. MC content in BCCs ranged from 1.0 to 31 cells/hpf. The number of T cells ranged from 0 to 50 cells/hpf with helper/suppressor cell ratios of 0.2 to 10. There was no correlation between helper/suppressor ratios and mast cell numbers; however, an inverse relationship was observed between the numbers of T cells and the number of mast cells in these tumors. These studies indicate that T cells and MCs are the primary immune cell populations responding to BCCs, and that decreased numbers of T cells are associated with more aggressive tumors.</description><identifier>ISSN: 0303-6987</identifier><identifier>EISSN: 1600-0560</identifier><identifier>DOI: 10.1111/j.1600-0560.1996.tb01287.x</identifier><identifier>PMID: 8721448</identifier><identifier>CODEN: JCUPBN</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Biological and medical sciences ; Carcinoma, Basal Cell - immunology ; Carcinoma, Basal Cell - pathology ; Dermatology ; Humans ; Leukocyte Count ; Lymphocyte Count ; Lymphocytes, Tumor-Infiltrating - pathology ; Mast Cells - immunology ; Medical sciences ; Skin Neoplasms - immunology ; Skin Neoplasms - pathology ; T-Lymphocytes - immunology ; Tumors of the skin and soft tissue. Premalignant lesions</subject><ispartof>Journal of cutaneous pathology, 1996-04, Vol.23 (2), p.140-146</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4360-aa26b14fd9b0f7dcac90157d5794302ad8a3a782191efd3dd1271864ac2649af3</citedby><cites>FETCH-LOGICAL-c4360-aa26b14fd9b0f7dcac90157d5794302ad8a3a782191efd3dd1271864ac2649af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0560.1996.tb01287.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0560.1996.tb01287.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3036210$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8721448$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deng, J.S.</creatorcontrib><creatorcontrib>Brod, B.A.</creatorcontrib><creatorcontrib>Saito, R.</creatorcontrib><creatorcontrib>Tharp, M.D.</creatorcontrib><title>Immune-associated cells in basal cell carcinomas of skin</title><title>Journal of cutaneous pathology</title><addtitle>J Cutan Pathol</addtitle><description>Increased numbers of mast cells (MCs) and lymphocytes infiltrating in basal cell carcinomas (BCCs) have been observed. The presence of these infiltrating cells has been considered a sign of an immunologic anti‐tumor response in the host, but the relationship of these two cell populations has not been examined. To elucidate this possible relationship, 30 non‐ulcerated BCCs were analyzed. Frozen sections of the tumors were stained with monoclonal antibodies for Langerhans' cells, lymphocyte subsets and natural killer cells. Fluorescein isothiocynate (FITC) ‐aviclin as well as anti‐tryptase and anti‐CD45RO monoclonal antibodies were used on formalin‐fixed, paraffin‐embedded secdons for mast cell and T cell identification, respectively. B cells and natural killer cells were rarely observed in these tumors. MCs and T cells were quantified by direct enumeration and expressed as number of cells per high power field (hpf). FITC‐avidin and anti‐tryptase antibodies were equivalent in their ability to identify MCs. MC content in BCCs ranged from 1.0 to 31 cells/hpf. The number of T cells ranged from 0 to 50 cells/hpf with helper/suppressor cell ratios of 0.2 to 10. There was no correlation between helper/suppressor ratios and mast cell numbers; however, an inverse relationship was observed between the numbers of T cells and the number of mast cells in these tumors. These studies indicate that T cells and MCs are the primary immune cell populations responding to BCCs, and that decreased numbers of T cells are associated with more aggressive tumors.</description><subject>Biological and medical sciences</subject><subject>Carcinoma, Basal Cell - immunology</subject><subject>Carcinoma, Basal Cell - pathology</subject><subject>Dermatology</subject><subject>Humans</subject><subject>Leukocyte Count</subject><subject>Lymphocyte Count</subject><subject>Lymphocytes, Tumor-Infiltrating - pathology</subject><subject>Mast Cells - immunology</subject><subject>Medical sciences</subject><subject>Skin Neoplasms - immunology</subject><subject>Skin Neoplasms - pathology</subject><subject>T-Lymphocytes - immunology</subject><subject>Tumors of the skin and soft tissue. Premalignant lesions</subject><issn>0303-6987</issn><issn>1600-0560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkFtr3DAQhUVpSTdJf0LBhJI3bzWWrEseAsmSpoHQhtDQRzGWZNDGl8SzSzf_vnbX7HvnRYzOmTPDx9gZ8CWM9XW9BMV5zks1flirlpuKQ2H0cveOLQ7Se7bggotcWaM_smOiNeegjCqP2JHRBUhpFszcte22izkS9T7hJobMx6ahLHVZhYTNvzbzOPjU9S1S1tcZPafulH2osaH4aX5P2NO3m1-r7_n9z9u71dV97qVQPEcsVAWyDrbitQ4eveVQ6lBqKwUvMBgUqE0BFmIdRAhQaDBKoi-UtFiLE3a-z30Z-tdtpI1rE003YRf7LTltQIIuYTRe7I1-6ImGWLuXIbU4vDngbsLm1m5i4yY2bsLmZmxuNw5_nrdsqzaGw-jMadS_zDqSx6YesPOJDrYRsyqAj7bLve1PauLbfxzgVk8PIKeAfB-QaBN3hwAcnp3SQpfu949bJ8WjfLT82hnxFzyol00</recordid><startdate>199604</startdate><enddate>199604</enddate><creator>Deng, J.S.</creator><creator>Brod, B.A.</creator><creator>Saito, R.</creator><creator>Tharp, M.D.</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199604</creationdate><title>Immune-associated cells in basal cell carcinomas of skin</title><author>Deng, J.S. ; Brod, B.A. ; Saito, R. ; Tharp, M.D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4360-aa26b14fd9b0f7dcac90157d5794302ad8a3a782191efd3dd1271864ac2649af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Carcinoma, Basal Cell - immunology</topic><topic>Carcinoma, Basal Cell - pathology</topic><topic>Dermatology</topic><topic>Humans</topic><topic>Leukocyte Count</topic><topic>Lymphocyte Count</topic><topic>Lymphocytes, Tumor-Infiltrating - pathology</topic><topic>Mast Cells - immunology</topic><topic>Medical sciences</topic><topic>Skin Neoplasms - immunology</topic><topic>Skin Neoplasms - pathology</topic><topic>T-Lymphocytes - immunology</topic><topic>Tumors of the skin and soft tissue. Premalignant lesions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deng, J.S.</creatorcontrib><creatorcontrib>Brod, B.A.</creatorcontrib><creatorcontrib>Saito, R.</creatorcontrib><creatorcontrib>Tharp, M.D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of cutaneous pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deng, J.S.</au><au>Brod, B.A.</au><au>Saito, R.</au><au>Tharp, M.D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immune-associated cells in basal cell carcinomas of skin</atitle><jtitle>Journal of cutaneous pathology</jtitle><addtitle>J Cutan Pathol</addtitle><date>1996-04</date><risdate>1996</risdate><volume>23</volume><issue>2</issue><spage>140</spage><epage>146</epage><pages>140-146</pages><issn>0303-6987</issn><eissn>1600-0560</eissn><coden>JCUPBN</coden><abstract>Increased numbers of mast cells (MCs) and lymphocytes infiltrating in basal cell carcinomas (BCCs) have been observed. The presence of these infiltrating cells has been considered a sign of an immunologic anti‐tumor response in the host, but the relationship of these two cell populations has not been examined. To elucidate this possible relationship, 30 non‐ulcerated BCCs were analyzed. Frozen sections of the tumors were stained with monoclonal antibodies for Langerhans' cells, lymphocyte subsets and natural killer cells. Fluorescein isothiocynate (FITC) ‐aviclin as well as anti‐tryptase and anti‐CD45RO monoclonal antibodies were used on formalin‐fixed, paraffin‐embedded secdons for mast cell and T cell identification, respectively. B cells and natural killer cells were rarely observed in these tumors. MCs and T cells were quantified by direct enumeration and expressed as number of cells per high power field (hpf). FITC‐avidin and anti‐tryptase antibodies were equivalent in their ability to identify MCs. MC content in BCCs ranged from 1.0 to 31 cells/hpf. The number of T cells ranged from 0 to 50 cells/hpf with helper/suppressor cell ratios of 0.2 to 10. There was no correlation between helper/suppressor ratios and mast cell numbers; however, an inverse relationship was observed between the numbers of T cells and the number of mast cells in these tumors. These studies indicate that T cells and MCs are the primary immune cell populations responding to BCCs, and that decreased numbers of T cells are associated with more aggressive tumors.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>8721448</pmid><doi>10.1111/j.1600-0560.1996.tb01287.x</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0303-6987
ispartof Journal of cutaneous pathology, 1996-04, Vol.23 (2), p.140-146
issn 0303-6987
1600-0560
language eng
recordid cdi_proquest_miscellaneous_78141751
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Biological and medical sciences
Carcinoma, Basal Cell - immunology
Carcinoma, Basal Cell - pathology
Dermatology
Humans
Leukocyte Count
Lymphocyte Count
Lymphocytes, Tumor-Infiltrating - pathology
Mast Cells - immunology
Medical sciences
Skin Neoplasms - immunology
Skin Neoplasms - pathology
T-Lymphocytes - immunology
Tumors of the skin and soft tissue. Premalignant lesions
title Immune-associated cells in basal cell carcinomas of skin
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T16%3A33%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immune-associated%20cells%20in%20basal%20cell%20carcinomas%20of%20skin&rft.jtitle=Journal%20of%20cutaneous%20pathology&rft.au=Deng,%20J.S.&rft.date=1996-04&rft.volume=23&rft.issue=2&rft.spage=140&rft.epage=146&rft.pages=140-146&rft.issn=0303-6987&rft.eissn=1600-0560&rft.coden=JCUPBN&rft_id=info:doi/10.1111/j.1600-0560.1996.tb01287.x&rft_dat=%3Cproquest_cross%3E78141751%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78141751&rft_id=info:pmid/8721448&rfr_iscdi=true